Antibiotice S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was RON 2.98 million compared to RON 3.81 million a year ago. Net income was RON 14.73 million compared to net loss of RON 4.49 million a year ago. Basic earnings per share from continuing operations was RON 0.0219 compared to basic loss per share from continuing operations of RON 0.0067 a year ago.
For the nine months, sales was RON 9.56 million compared to RON 9.41 million a year ago. Net income was RON 76.73 million compared to RON 29.49 million a year ago. Basic earnings per share from continuing operations was RON 0.1143 compared to RON 0.0439 a year ago.